World Orphan Drug Congress 2016

Make sure you are at the forefront of the orphan drug industry. Regardless of whether your interest lies in research, clinical development, patient access, global pricing and reimbursement or just to engage with patient advocacy groups more intimately, we have content, networking and potential partners for you! By bringing experts from patients and all stakeholders under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of orphan drug research, development and manufacture. Take just three days out of the office to meet with 450+ potential customers who need to find solutions to challenges around the commercial, regulatory and scientific issues in orphan drugs. Key speakers include: Yann Le Cam, Chief Executive Officer, EURORDIS Dr Ségolène Aymé, Founder of Orphanet, Emeritus Research Director, INSERM Dr Bruno Sepodes and many more...